ADCYAP1 and early-onset autosomal dominant Alzheimer disease: Furthermore, evidence from previous studies suggests that PACAP can enhance cognitive abilities by inhibiting the deposition of Aβ and Tau, and promoting the clearance of Tau and Aβ aggregates in Alzheimer's disease mice 39, 40.